BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 113807)

  • 21. Long-term amitriptyline in chronic depression.
    Giller E; Bialos D; Harkness L; Jatlow P; Waldo M
    Hillside J Clin Psychiatry; 1985; 7(1):16-33. PubMed ID: 3894196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response.
    Mendlewicz J; Linkowski P; Rees JA
    Br J Psychiatry; 1980 Feb; 136():154-60. PubMed ID: 6989426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tricyclic plasma levels. Effect of age, race, sex, and smoking.
    Ziegler VE; Biggs JT
    JAMA; 1977 Nov; 238(20):2167-9. PubMed ID: 578829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic findings in patients undergoing amitriptyline treatment.
    Ziegler VE; Biggs JT
    Dis Nerv Syst; 1977 Sep; 38(9):697-9. PubMed ID: 902559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amitriptyline plasma levels and therapeutic response.
    Ziegler VE; Co BT; Taylor JR; Clayton PJ; Biggs JT
    Clin Pharmacol Ther; 1976 Jun; 19(6):795-801. PubMed ID: 773587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amitriptyline nortriptyline plasma levels and therapeutic response in depressed women.
    Corona GL; Fenoglio L; Pinelli P; Zerbi F
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):299-308. PubMed ID: 360244
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum levels and response to amitriptyline in depressed out-patients.
    Rowan PR; Paykel ES; Marks V; Mould G; Bhat A
    Neuropsychobiology; 1984; 12(1):9-15. PubMed ID: 6514181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of tricyclic antidepressant therapy.
    Dawling S
    Clin Biochem; 1982 Feb; 15(1):56-61. PubMed ID: 7067078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of commercially available tricyclic antidepressant levels.
    Amsterdam JD; Brunswick DJ; Mendels J
    J Clin Psychiatry; 1980 Jun; 41(6):206-7. PubMed ID: 7380819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EEG sleep and tricyclic blood levels: acute and chronic administration in depression.
    Kupfer DJ; Hanin I; Coble PA; Spiker DG; Sorisio D; Grau TG
    J Clin Psychopharmacol; 1982 Feb; 2(1):8-13. PubMed ID: 7068946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.
    Coppen A; Ghose K; Montgomery S; Rama Rao VA; Bailey J; Christiansen J; Mikkleson PL; van Praag HM; van de Poel F; Minsker EJ; Kozulja VG; Matussek N; Kungkunz G; Jłrgensen A
    Lancet; 1978 Jan; 1(8055):63-6. PubMed ID: 74566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG sleep and tricyclic plasma levels in primary depression.
    Kupfer DJ; Hanin I; Spiker DG; Neil J; Coble P
    Commun Psychopharmacol; 1979; 3(2):73-80. PubMed ID: 223806
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.